Physician profile
Jonathan Levi Williamson
NPI 1558592337
$3,800.74
in general payments reported to CMS, 2019-2025
9 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $76.04 · 2021: $82.46 · 2022: $91.39 · 2023: $1,395 · 2024: $1,064 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,467 · Travel and Lodging: $1,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,466.68 |
| Travel and Lodging | $1,376.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,542.77 | 2020-2025 | Prostep, Infinity, Asnis |
| Paragon 28, INC. | $1,215.14 | 2023-2025 | Apex 3d, Additive Orthopedics, Silverback |
| Wright Medical Technology, INC. | $569.70 | 2019-2020 | |
| Smith+Nephew, INC. | $221.04 | 2019-2023 | Grafix Pl |
| Djo, LLC | $150.63 | 2019 | |
| Tactile Systems Technology INC | $38.81 | 2020-2024 | Flexitouch Plus, Entre Plus |
| Averitas Pharma INC. | $35.31 | 2024-2025 | Qutenza |
| Kerecis Limited | $24.89 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Orthofix Medical, INC. | $2.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Williamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.